By Claudia Assis, MarketWatch
Shares look poised to end five-day losing streak
SAN FRANCISCO (MarketWatch) -- One of Wall Street's biggest boosters of Tesla Motors Inc. cut his sales forecasts for a key new model promised by the electric-car maker and slashed his price target for the stock by 9.4%.
One of the reasons?
By Victor Reklaitis, MarketWatch
Oracle, FedEx, Volcano also in focus
NEW YORK (MarketWatch) -- These are stocks making notable moves on Wednesday:
Energy-related stocks were the best performers by far in the S&P 500, helped by crude oil bouncing back after falling hard for weeks.
William DePond, M.D.
WEST PALM BEACH, FL --
Praxair, Inc. (NYSE:PX) today announced the release of its new Grab
'n Go Digital Advanced Oxygen System, the latest evolution of its Grab
'n Go medical oxygen offerings, all-in-one portable units that have
become the go-to solution for many health care facilities.
Pharma Inc. (Nasdaq: CERU), a leader in Dynamic Tumor Targeting™,
today announced that the first patient has been dosed with CRLX301 in
Cerulean’s Phase 1/2a trial in patients with advanced solid tumor
Affiliated Managers Group, Inc. (NYSE: AMG) today announced it has
agreed to a transaction which will result in a meaningful increase in
its minority investment in AQR Capital Management, LLC, a leading global
investment manager and an AMG Affiliate since 2004.
Sign-up for 2014/12/17 - Roberts Realty Investors, Inc. Announces Filing Of Preliminary Proxy Statement For Special Meeting Of Shareholders And Provides Update On Filing Of Compliance Plan investment picks
The randomized, double-blind, placebo-controlled Phase III study with RHB-102 for acute gastroenteritis and gastritis (the GUARD study) is underway in the U.S., with a planned enrollment of 320 patients Top-line results from the Phase III GUARD study are expected during H2/2015 RedHill recently submitted a European Marketing Authorization Application (MAA) seeking approval of RHB-102 , newly branded as BEKINDA ™ , for cancer patients suffering from chemotherapy and radiotherapy-induced nausea and vomiting
TEL-AVIV, Israel, Dec.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.